Dominik Hartl1. 1. Children's Hospital, University of Tübingen, Tübingen, Germany and Roche Pharma Research & Early Development (pRED), Immunology, Inflammation and Infectious Diseases (I3) Discovery and Translational Area, Roche Innovation Center, Basel, Switzerland.
Authors: Ohn A Chow; Maren von Köckritz-Blickwede; A Taylor Bright; Mary E Hensler; Annelies S Zinkernagel; Anna L Cogen; Richard L Gallo; Marc Monestier; Yanming Wang; Christopher K Glass; Victor Nizet Journal: Cell Host Microbe Date: 2010-11-18 Impact factor: 21.023
Authors: Devin M Boe; Brenda J Curtis; Michael M Chen; Jill A Ippolito; Elizabeth J Kovacs Journal: J Leukoc Biol Date: 2015-04-15 Impact factor: 4.962
Authors: Bryan G Yipp; Björn Petri; Davide Salina; Craig N Jenne; Brittney N V Scott; Lori D Zbytnuik; Keir Pittman; Muhammad Asaduzzaman; Kaiyu Wu; H Christopher Meijndert; Stephen E Malawista; Anne de Boisfleury Chevance; Kunyan Zhang; John Conly; Paul Kubes Journal: Nat Med Date: 2012-09 Impact factor: 53.440